US equities |
SPCX $175.33 ▲+2.48% NVDA $241.82 ▲+1.22% MU $1,067.17 ▲+0.30% MRVL $299.81 ▲+10.53% AMD $638.48 ▲+1.07% SNDK $1,692.89 ▼-0.66% TSLA $380.11 ▲+0.36% META $743.55 ▲+0.22%
FinancialContent

Latest News about Biotech

Recent news which mentions Biotech

< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
32 33 Next >
FDA Halts Trials Exporting Americans' Cells To Hostile Countries For Genetic Engineering
Tickers CRBU CRSP LLY NEWS
Tags VRTX FDA News
From Benzinga
FDA Approves Regeneron Sanofi Treatment For Rare Autoimmune Skin Disorder
Tickers NEWS REGN SNY
Tags Health Care Briefs SNY
From Benzinga
FDA Approves Gilead's 'Game Changing' Twice-Yearly Shot To Prevent HIV Transmission, Critics Slam $28K Price Tag
Tickers GILD GSK NEWS
Tags Stories That Matter Top Stories News
From Benzinga
Eli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst
Tickers BEAM CRSP EDIT LLY
Tags Analyst Ratings VERV Briefs
From Benzinga
AbbVie's Migraine Drug Outperforms Generic Treatment In Head-To-Head Trial
Tickers ABBV NEWS
Tags Stories That Matter Biotech Benzinga
From Benzinga
Aptevo Therapeutics Touts Data From Investigational Drug Trial For Aggressive Blood Cancer
Tickers APVO NEWS
Tags Trading Ideas News Market News
From Benzinga
Scholar Rock's Atrophy Drug When Combined With Eli Lilly's Zepbound Shows Around 55% Better Muscle Preservation In Weight Loss Study
Tickers LLY NEWS NVO REGN
Tags Weight Loss REGN NVO
From Benzinga
EXCLUSIVE: Telomir Pharmaceuticals Says Preclinical Drug Candidate Prevents Premature Aging In Patient-Derived Cells From Children With Progeria
Tickers NEWS TELO
Tags Exclusives Market News News
From Benzinga
FDA Introduces Tumor Board-Style Reviews For Faster Drug Decisions
Tickers NEWS
Tags FDA News Briefs
From Benzinga
Gilead's HIV Prevention Drug Could Be Manufactured At Shocking Low Cost: Report
Tickers GILD NEWS
Tags Movers Biotech Benzinga
From Benzinga
Why Is Dyne Therapeutics Stock Trading Lower On Tuesday?
Tickers DYN NEWS
Tags Top Stories Stories That Matter Market News
From Benzinga
AbbVie's Cancer Drug Venetoclax Falls Short In Phase 3 Combination Trial For Myelodysplastic Syndromes
Tickers ABBV NEWS
Tags Market News News ABBV
From Benzinga
Mineralys Therapeutics: Investigational Drug Shows Benefit In Hypertensive Patients With Chronic Kidney Disease, Stock Jumps
Tickers MLYS NEWS
Tags Benzinga Biotech Movers
From Benzinga
Eli Lilly Expands Into Gene Editing With Verve Therapeutics Acquisition
Tickers LLY NEWS VERV
Tags Biotech Movers Benzinga
From Benzinga
Supernus Pharma Acquires Maker Of Postpartum Depression Drug Zurzuvae In $795 Million Deal
Tickers BIIB NEWS SAGE SUPN
Tags Briefs Health Care why it's moving
From Benzinga
Eli Lilly Launches Flat Pricing For Zepbound, Capping Monthly Cost At $499
Tickers LLY NEWS
Tags Large Cap General Benzinga
From Benzinga
< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
32 33 Next >